Antibody Engineering & Therapeutics Europe Takes Center Stage in Basel, Europe’s Premier Pharma Hub

March 13, 2025 02:16 AM AEDT | By EIN Presswire
 Antibody Engineering & Therapeutics Europe Takes Center Stage in Basel, Europe’s Premier Pharma Hub
Image source: EIN Presswire

Antibody Engineering & Therapeutics Europe returns to Basel, Europe's pharma hub, June 10-12, 2025, uniting experts to advance antibody science. BASEL, SWITZERLAND, March 12, 2025 /EINPresswire.com/ -- Informa Connect, a leading provider of business intelligence and industry events, is pleased to announce the Antibody Engineering & Therapeutics Europe conference, taking place in Basel from June 10-12, 2025.

Antibody Engineering & Therapeutics Europe:
Date: June 10-12, 2025
Location: Congress Center | Basel Switzerland

Antibody Engineering & Therapeutics Europe will convene over 350 leading researchers, scientists, and industry professionals to explore the latest advancements in antibody engineering and their therapeutic applications. The conference will cover a wide array of topics, including:

• Emerging In Vitro Approaches to Antibody Discovery
• Advanced In Vivo Antibody Discovery
• Enhanced Therapeutic Function Through Fc Engineering
• Multi-specific Engineering
• Agonist Antibodies, Co-stimulation & Combination Therapy
• Beyond IgG: Next-gen Therapeutic Scaffolds & Antibody Formats
• Therapeutic Antibody Applications Beyond Oncology
• Antibodies for Autoimmune Disease
• Innovations with Antibody Payloads

Key highlights of the conference include:
• Presentations from world-renowned pioneers who are front and centre of the experience.
• Interactive workshops and poster presentations showcasing cutting-edge research from peers.
• Networking opportunities with colleagues from around the globe.

“An excellent interaction of academia and pharma, conducive to enhanced collaboration in the development of antibody science in Europe!”
- Gordana Wozniak-Knopp, Phd, BOKU

The sister-conference to the San Diego meeting, Antibody Engineering & Therapeutics US, the European counterpart promises to deliver critical insights in an environment designed to cultivate discussions that will propel the industry forward. With a programme created in conjunction with The Antibody Society, the mix of academia and industry enables a knowledge-hub unlike any other.

“Coming from academia, I see the Antibody Engineering & Therapeutics conference to be a great opportunity to explore an industry perspective. It showcases the high-quality research and cutting edge technologies used in the forefront of antibody research and development. It opened my eyes to other opportunities outside academia and the direct impact of research done in industry aiming to improve human health.”
- Rodrigo Arcoverde Cerveira Da Silva, Karolinska Institutet

Informa Connect are thrilled to welcome you to London for this “must-attend” antibody event.

Registration information for Antibody Engineering & Therapeutics Europe is available online. Early bird rates are available until 16 May 2025.
For more information please visit the conference website at:
https://informaconnect.com/antibody-engineering-europe/

About Informa Connect
We have millions of professional and commercial customers. Our mission is to give them access to extraordinary people and exceptional insight.
We provide unique opportunities to learn, establish relationships and do business. We do this through a range of products and services, from digital platforms to live events.

For more information, please visit https://informaconnect.com/.

Felicity Bell
Informa Connect
[email protected]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.